EPISODE · Oct 11, 2023 · 46 MIN
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
from Oncology Today with Dr Neil Love
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here
Embed this episode
Ready to play
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
0:00
46:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 46 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on October 11, 2023.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!